Imperial College London has secured £22.5m from the UK Government to accelerate the development of a potential Covid-19 vaccine.
Since February, researchers at Imperial have been studying a self-amplifying RNA vaccine candidate in animals.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The government funding will be used to support Phase II trials and to make preparations for a large Phase III trial.
